Investigational Drug Information for Seletracetam
✉ Email this page to a colleague
What is the development status for investigational drug Seletracetam?
Seletracetam is an investigational drug.
There have been 5 clinical trials for Seletracetam.
The most recent clinical trial was a Phase 2 trial, which was initiated on February 1st 2006.
The most common disease conditions in clinical trials are Epilepsy, Epilepsies, Partial, and Seizures. The leading clinical trial sponsors are UCB Pharma and [disabled in preview].
Summary for Seletracetam
US Patents | 0 |
International Patents | 0 |
US Patent Applications | 388 |
WIPO Patent Applications | 210 |
Japanese Patent Applications | 6 |
Clinical Trial Progress | Phase 2 (2006-02-01) |
Vendors | 25 |
Recent Clinical Trials for Seletracetam
Title | Sponsor | Phase |
---|---|---|
Open Label Trial to Study the Long-term Safety and Efficacy of Seletracetam for the Treatment of Epilepsy | UCB Pharma | Phase 3 |
A Study to Evaluate the Efficacy and Safety of Seletracetam in Adult Patients With Refractory Partial Onset Seizures | UCB Pharma | Phase 2/Phase 3 |
Open Label Study (Everyone Who Participates Receives Drug) to Further Determine How Safe and Effective Oral Treatment of Seletracetam is in Patients With Refractory Epilepsy. | UCB Pharma | Phase 3 |
Clinical Trial Summary for Seletracetam
Top disease conditions for Seletracetam
Top clinical trial sponsors for Seletracetam
US Patents for Seletracetam
Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
---|---|---|---|---|
>Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |